CN101310013B - 人平滑肌细胞的获得方法及其用途 - Google Patents

人平滑肌细胞的获得方法及其用途 Download PDF

Info

Publication number
CN101310013B
CN101310013B CN2006800428874A CN200680042887A CN101310013B CN 101310013 B CN101310013 B CN 101310013B CN 2006800428874 A CN2006800428874 A CN 2006800428874A CN 200680042887 A CN200680042887 A CN 200680042887A CN 101310013 B CN101310013 B CN 101310013B
Authority
CN
China
Prior art keywords
cell
people
cells
obtains
substratum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800428874A
Other languages
English (en)
Chinese (zh)
Other versions
CN101310013A (zh
Inventor
索菲·勒里库瑟
玛丽-诺乐·拉卡萨尼
让-皮埃尔·马若里奥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute Of Vascular And Blood Research
Assistance Publique - Hôpitaux de Paris
Original Assignee
Institute Of Vascular And Blood Research
Assistance Publique - Hôpitaux de Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute Of Vascular And Blood Research, Assistance Publique - Hôpitaux de Paris filed Critical Institute Of Vascular And Blood Research
Publication of CN101310013A publication Critical patent/CN101310013A/zh
Application granted granted Critical
Publication of CN101310013B publication Critical patent/CN101310013B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
CN2006800428874A 2005-09-19 2006-09-19 人平滑肌细胞的获得方法及其用途 Expired - Fee Related CN101310013B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0509557 2005-09-19
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (2)

Publication Number Publication Date
CN101310013A CN101310013A (zh) 2008-11-19
CN101310013B true CN101310013B (zh) 2011-09-07

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800428874A Expired - Fee Related CN101310013B (zh) 2005-09-19 2006-09-19 人平滑肌细胞的获得方法及其用途

Country Status (10)

Country Link
US (1) US20090269310A1 (cg-RX-API-DMAC7.html)
EP (1) EP1934333B9 (cg-RX-API-DMAC7.html)
JP (1) JP2009508511A (cg-RX-API-DMAC7.html)
CN (1) CN101310013B (cg-RX-API-DMAC7.html)
AT (1) ATE531791T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006293814B2 (cg-RX-API-DMAC7.html)
CA (1) CA2622916A1 (cg-RX-API-DMAC7.html)
FR (1) FR2890977A1 (cg-RX-API-DMAC7.html)
IL (1) IL190289A0 (cg-RX-API-DMAC7.html)
WO (1) WO2007034069A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
ES2689932T3 (es) * 2008-11-04 2018-11-16 Inregen Construcciones de armazones de células
KR102780297B1 (ko) * 2017-12-14 2025-03-12 이노바셀 바이오테크놀로지 아게 근육 유래 세포를 수득하는 방법
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法
KR20220002315A (ko) * 2019-03-22 2022-01-06 이노바셀 아게 유도된 평활근 세포를 수득하는 방법
CN120418415A (zh) * 2022-12-28 2025-08-01 因特斯迪姆株式会社 细胞组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Also Published As

Publication number Publication date
WO2007034069A1 (fr) 2007-03-29
AU2006293814B2 (en) 2011-09-29
CN101310013A (zh) 2008-11-19
IL190289A0 (en) 2011-08-01
US20090269310A1 (en) 2009-10-29
CA2622916A1 (fr) 2007-03-29
FR2890977A1 (fr) 2007-03-23
EP1934333B9 (fr) 2012-05-02
EP1934333B1 (fr) 2011-11-02
ATE531791T1 (de) 2011-11-15
EP1934333A1 (fr) 2008-06-25
JP2009508511A (ja) 2009-03-05
AU2006293814A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
JP5710709B2 (ja) ヒト骨髄由来内皮前駆細胞の同定、及び虚血性傷害後の心筋細胞の機能を改善するためのヒト骨髄由来内皮前駆細胞の使用
Kocher et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
Gojo et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells
Dazzi et al. The role of mesenchymal stem cells in haemopoiesis
Shiota et al. Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties
Burlacu et al. Promoting effect of 5-azacytidine on the myogenic differentiation of bone marrow stromal cells
WO2001048151A1 (en) Cells capable of differentiating into heart muscle cells
Corti et al. A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse
KR101721958B1 (ko) 심장 조직을 처치하는 세포를 이용하는 조성물 및 방법
US7658951B2 (en) Method of improving cardiac function of a diseased heart
CN103202857A (zh) 血管周围间充质前体细胞诱导的血管形成
Itescu et al. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function
JP2009531021A (ja) 骨格筋周囲血管芽細胞および心筋中胚葉性血管芽細胞、それらの単離および使用方法
Tang et al. VEGF-A promotes cardiac stem cell engraftment and myocardial repair in the infarcted heart
Chen et al. Danhong injection enhances the therapeutic efficacy of mesenchymal stem cells in myocardial infarction by promoting angiogenesis
WO2020157660A1 (en) Method for treating or preventing gastrointestinal bleeding
Spitkovsky et al. Adult mesenchymal stromal stem cells for therapeutic applications
CN113573720A (zh) 提高视力的方法
See et al. Therapeutic effects of human STRO‐3‐selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia
Bonaros et al. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure
Itescu et al. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function
AU2006293814B2 (en) Method for obtaining human smooth muscular cells and uses thereof
Norol et al. GFP-transduced CD34+ and Lin− CD34− hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct
WO2001048150A1 (en) Cells capable of differentiating into heart muscle cells
JP2009508511A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110907

Termination date: 20120919